TREATMENT AND DIAGNOSIS
Our catalog related to treatment and diagnosis includes:
• INDUSTRIAL PROPERTY (Patents, utility models, and associated know-how):
| CÓDIGO | TÍTULO | TIPO | DESCRIPCIÓN | PDF – OFERTA TECNOLÓGICA |
|---|---|---|---|---|
|
CÓDIGO
FCAD-21005
|
TÍTULO
Clinical panel with biomarkers for the detection of statin intolerance in patients at high cardiovascular risk
|
TIPO
Diagnosis (cardiology)
|
DESCRIPCIÓN
Uso de panel de miARNs como biomarcadores para la detección de intolerancia estatinas.
|
PDF – OFERTA TECNOLÓGICA
|
|
CÓDIGO
FCAD-21002
|
TÍTULO
Organic compounds for the treatment of diabetic retinopathy and nephropathy
|
TIPO
Therapy
|
DESCRIPCIÓN
A molecule with anti-inflammatory and chemopreventive potential in inflammatory processes in general, in diseases caused by underlying inflammatory processes, and in inflammatory processes related to the development of diabetes mellitus and its complications.
|
PDF – OFERTA TECNOLÓGICA
|
|
CÓDIGO
UCA-P201800246
|
TÍTULO
Composition capable of promoting the formation of neurons in culture and in brain injuries
|
TIPO
Therapy
|
DESCRIPCIÓN
Esta invención está relacionada con el empleo del compuesto EOF2 o una sal farmacológicamente activa de dicho compuesto, para favorecer la diferenciación a neuronas de precursores neurales o células madre neurales en cultivo y en lesiones cerebrales. Adicionalmente, también se relaciona con su empleo para el tratamiento de lesiones del SNC que cursen con pérdida neuronal.
|
PDF – OFERTA TECNOLÓGICA
ND
|
|
CÓDIGO
UCA-P201600138
|
TÍTULO
Uso de extracto de hoja de mango para el tratamiento de enfermedades neurodegenerativas
|
TIPO
Therapy
|
DESCRIPCIÓN
The present invention relates to the use of an extract for the preparation of a pharmaceutical or nutraceutical Composition useful in the treatment of CNS diseases characterized by inflammation. These are the most common forms of dementia and account for approximately 80% of cases.
|
PDF – OFERTA TECNOLÓGICA
Spanish (UCA website)
|
|
CÓDIGO
UCA-P201830615
|
TÍTULO
Methods for the diagnosis and/or treatment of neurodegenerative diseases
|
TIPO
Diagnosis, Treatment
|
DESCRIPCIÓN
An in vitro method for detecting at least one neurodegenerative disease, for monitoring the efficacy of a treatment and/or for predicting the response to a treatment, and for identifying compound candidates useful for treatment. Furthermore, the present invention relates to therapeutic targets for use in the treatment of neurodegenerative diseases, as well as to compounds capable of inhibiting said therapeutic targets, with the aim of improving the health of patients suffering from a neurodegenerative disease.
|
PDF – OFERTA TECNOLÓGICA
ND
|
|
CÓDIGO
FCAD-21002
|
TÍTULO
Computer-implemented method for converting a high-resolution digital image into a DICOM pyramid image
|
TIPO
ICT Diagnosis
|
DESCRIPCIÓN
A new computer-based method designed specifically to convert a high-resolution image—for example, an image obtained by scanning or digitizing a histological or cytological specimen in Pathology—from its original format to DICOM format.
|
PDF – OFERTA TECNOLÓGICA
ND
|
|
CÓDIGO
FCAD-23001
|
TÍTULO
Inhibidores farmacológicos de los inflamasomas NLRP1 y NLRP3
|
TIPO
Therapy
|
DESCRIPCIÓN
Specific inhibitors that simultaneously block the NLRP1 and NLRP3 inflammatory complexes, reducing IL-1β- and IL-18-mediated inflammation with low cellular toxicity, for the treatment of inflammatory diseases.
|
PDF – OFERTA TECNOLÓGICA
|
|
CÓDIGO
FCAD-23010
|
TÍTULO
Stabilized mixture based on natural sweeteners for the production of ice cream suitable for consumption by people with diabetes, manufacturing process, and uses
|
TIPO
Research Model
|
DESCRIPCIÓN
A stabilized blend of natural sweeteners, based on tagatose, designed for making ice cream suitable for people with diabetes, while maintaining texture, flavor, and quality without affecting blood sugar levels.
|
PDF – OFERTA TECNOLÓGICA
|
|
CÓDIGO
FCAD-24001
|
TÍTULO
Panel of protein markers for predicting cardiovascular events resulting from the atherosclerotic process
|
TIPO
Personalized Medicine
|
DESCRIPCIÓN
A panel of protein biomarkers to predict the progression of atherosclerosis in patients with dyslipidemia, enabling more accurate risk stratification and personalized management of cardiovascular disease.
|
PDF – OFERTA TECNOLÓGICA
|
|
CÓDIGO
FCAD-24002
|
TÍTULO
Development of modular and/or reversible chimeric antigen receptors (CARs) mediated by inteins
|
TIPO
Therapy
|
DESCRIPCIÓN
Use of split antigens to improve industrial processes, such as the modular creation of CAR receptors that recognize multiple antigens, the evaluation of protein domains without expressing complete molecules, and the dynamic modulation of CAR activity through the controlled removal of active domains.
|
PDF – OFERTA TECNOLÓGICA
|
|
CÓDIGO
INIBICA-25003
|
TÍTULO
Biomarkers for the Prediction and Diagnosis of Severe Atherosclerosis
|
TIPO
Diagnóstico (aterosclerosis severa)
|
DESCRIPCIÓN
A panel of protein biomarkers in blood designed to predict, provide early diagnosis, and guide the treatment of atherosclerotic cardiovascular diseases.
|
PDF – OFERTA TECNOLÓGICA
|
• INTELLECTUAL PROPERTY (know-how, software, app):
| CÓDIGO | TÍTULO | TIPO | DESCRIPCIÓN | PDF – OFERTA TECNOLÓGICA |
|---|---|---|---|---|
|
CÓDIGO
|
TÍTULO
MELAGE
|
TIPO
Diagnostic software
|
DESCRIPCIÓN
Software that facilitates the viewing and management of ultrasound and MRI scans of newborns' brains to improve the early diagnosis of motor and cognitive impairments.
|
PDF – OFERTA TECNOLÓGICA
|
If you have any trouble downloading the file mentioned above, you can access it via the following link.